Filing Flows › Aurinia Pharmaceuticals (AUPH) › Operating margin
Aurinia Pharmaceuticals (AUPH) operating margin by quarter
Aurinia Pharmaceuticals' operating margin was 42.3% in Q3 2026 (third quarter 2026), -13.4 pts from Q2 2026. Over the last 7 quarters it ranged from 28.7% (Q2 2025) to 55.7% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 42.3% | -13.4 pts | +1.8 pts |
| Q2 2026 | 55.7% | +2.4 pts | +27.0 pts |
| Q1 2026 | 53.3% | +10.2 pts | +18.3 pts |
| Q4 2025 | 43.1% | +2.6 pts | — |
| Q3 2025 | 40.5% | +11.8 pts | — |
| Q2 2025 | 28.7% | -6.3 pts | — |
| Q1 2025 | 35.0% | — | — |
Q3 2026 at a glance
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aurinia Pharmaceuticals' operating margin?
Aurinia Pharmaceuticals' operating margin was 42.3% in Q3 2026 (third quarter 2026), -13.4 pts from Q2 2026.
How has Aurinia Pharmaceuticals' operating margin changed?
Over the last 7 quarters it ranged from 28.7% (Q2 2025) to 55.7% (Q2 2026).
Q3 2026 results → · How Aurinia Pharmaceuticals makes money →